Related Experiment Video
Updated: Sep 17, 2026

Diagnosis of Neoplasia in Barrett’s Esophagus using Vital-dye Enhanced Fluorescence Imaging
Published on: May 11, 2014
The Baader-Meinhof Phenomenon of Dieulafoy's Lesion
Sindhura Kolli1, Khoi Paul Dang-Ho1, Amit Mori2
1Internal Medicine, The Brooklyn Hospital Center, Affiliate of the Mount Sinai Hospital, Brooklyn, USA.
Abstract:
Despite modern investigative innovations in the cutting edge field of gastroenterology, we are reminded of our contemporary limitations when we encounter the ever evasive Dieulafoy's lesion (DL). Ever since it has been initially described in 1884, its rare but frustrating presence creates a calamitous situation. Even more so when it presents atypically, much like it did in our patient. This review of DL delves into the history, epidemiology, characteristics, the most current and innovative diagnostic measures available, as well as treatment and prevention of recurrence of these obscure gastrointestinal (GI) bleeding sources.
Insights
Dieulafoy's lesions (DL) are rare but serious gastrointestinal bleeding sources. This review covers their history, diagnosis, and management, highlighting current challenges and innovations.
Area of Science:
- Gastroenterology
- Gastrointestinal Endoscopy
- Vascular Anomalies
Background:
- Dieulafoy's lesions (DL) are an uncommon cause of gastrointestinal bleeding.
- Despite advances, DL diagnosis and management remain challenging.
- Atypical presentations of DL can complicate clinical recognition.
Purpose of the Study:
- To provide a comprehensive review of Dieulafoy's lesions.
- To discuss the historical context, epidemiology, and clinical characteristics of DL.
- To explore current diagnostic modalities and therapeutic strategies for DL.
Main Methods:
- Literature review of Dieulafoy's lesions.
- Analysis of diagnostic techniques including endoscopy and imaging.
- Review of treatment options, including endoscopic hemostasis and surgical interventions.
Main Results:
- Dieulafoy's lesions are characterized by an aberrant, large submucosal artery.
- Endoscopy is the primary diagnostic tool, often revealing active bleeding.
- Treatment success rates vary, with endoscopic interventions being preferred.
Conclusions:
- Dieulafoy's lesions require a high index of suspicion for diagnosis.
- Innovative endoscopic techniques have improved management outcomes.
- Further research is needed to optimize prevention of Dieulafoy's lesion recurrence.
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease II: Ulcerative Colitis
Diverticular Disease of the Colon
![Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F60445.jpg&w=3840&q=50)
